Psychiatry and Neurology, Neurology · Dothan, AL
NPI
1851366009
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
348 Healthwest Dr
Dothan, AL, 36303
Phone (334) 944-7006
Groups this clinician bills Medicare through
Medicare paid, 2024
$213K
3,852 services
Medicare patients, 2024
1,306
Average age 73
Drug cost, 2024
$5.2M
7,166 prescriptions
Company payments, 2025
$4,463
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hassan Kesserwani was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 1,434 times for 149 patients. In total Hassan Kesserwani billed 3,852 services in 45 codes, and Medicare paid $213K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,434 | 149 | $0.08 | $116 |
| 99204 Office E&M - New | Office | 530 | 530 | $105.50 | $56K |
| 99214 Office E&M - Established | Office | 327 | 281 | $78.54 | $26K |
| 95886 Electrical Nerve Conductivity | Office | 285 | 272 | $66.52 | $19K |
| 99213 Office E&M - Established | Office | 186 | 174 | $60.56 | $11K |
| 95911 Electrical Nerve Conductivity | Office | 151 | 144 | $144.61 | $22K |
| 99203 Office E&M - New | Office | 140 | 140 | $81.22 | $11K |
| 64405 Musculoskeletal | Office | 139 | 96 | $62.35 | $8,666 |
| 95909 Electrical Nerve Conductivity | Office | 102 | 102 | $88.82 | $9,060 |
| 95816 Neurologic | Facility | 75 | 72 | $39.45 | $2,959 |
| 93660 Cardiography | Office | 67 | 67 | $114.58 | $7,677 |
| 93886 Ultrasound - Nonspecific | Office | 50 | 49 | $176.05 | $8,803 |
| 95885 Electrical Nerve Conductivity | Office | 40 | 39 | $43.61 | $1,744 |
| 20526 Musculoskeletal | Office | 37 | 31 | $69.97 | $2,589 |
| 96372 Injection Administration | Office | 22 | 22 | $10.38 | $228 |
By year: 2022 $247K for 4,437 services; 2023 $240K for 4,086 services; 2024 $213K for 3,852 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 25 | 25 | $2.94 | $73.5 |
Medicare prescription drug claims, 2024
In 2024, the drug Hassan Kesserwani prescribed most often to Medicare patients was Donepezil Hcl, with 988 prescriptions and refills. In total Hassan Kesserwani wrote 7,166 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 988 | 1,505 | 277 | $5,950 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 444 | 720 | 120 | $10K |
| Levetiracetam Generic | 405 | 607 | 103 | $7,578 |
| Gabapentin Generic | 382 | 452 | 96 | $4,120 |
| Memantine Hcl Generic | 335 | 467 | 88 | $7,956 |
| Tizanidine Hcl Generic | 326 | 439 | 112 | $2,668 |
| Topiramate Generic | 278 | 386 | 87 | $2,738 |
| Quetiapine Fumarate Generic | 209 | 255 | 58 | $1,790 |
| Aimovig Autoinjector Erenumab-Aooe | 202 | 221 | 58 | $165K |
| Primidone Generic | 183 | 268 | 58 | $1,845 |
| Pyridostigmine Bromide Generic | 170 | 221 | 45 | $9,672 |
| Botox Onabotulinumtoxina | 154 | 403 | 71 | $250K |
| Zonisamide Generic | 114 | 196 | 37 | $1,673 |
| Lacosamide Generic | 113 | 123 | 21 | $7,272 |
| Amitriptyline Hcl Generic | 99 | 127 | 36 | $921 |
Brand drugs: 1,177 claims; generic drugs: 5,962 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hassan Kesserwani $4,463 ($4,463 in general payments such as food, travel and fees) from 26 companies. The largest payer was Argenx US, Inc. with $394.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 13 | $394 |
| Amgen Inc. AMGN | 14 | $387 |
| UCB, Inc. UCB.BR | 15 | $360 |
| Neurocrine BioSciences, Inc. NBIX | 14 | $303 |
| Abbvie Inc. ABBV | 27 | $301 |
| Alexion Pharmaceuticals, Inc. AZN | 11 | $269 |
| Pfizer Inc. PFE | 13 | $256 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 12 | $254 |
| Genentech USA, Inc. ROG.SW | 10 | $236 |
| Mallinckrodt Hospital Products Inc. | 9 | $214 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.